Cara Therapeutics | CARA - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Cara Therapeutics USD 4.62M 1.4M 2026-03
Cassava Sciences USD 39.19M 2.46M 2026-03
Chugai Pharma JPY 160.7B 53.18B 2026-06
Cipla INR 32.3B 1.95B 2026-03
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.53M 173K 2026-03
CSL USD 3.17B 290M 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
J&J USD 9.22B 1.24B 2026-06
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Pacira USD 14.01M 1.14M 2026-03
Pfizer USD 4.51B 734M 2026-03
RedHill Biopharma USD 731K 104K 2025-12
Supernus Pharmaceuticals USD 5.59M 4.58M 2026-06
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12